Biochemical events accompanying macrophage activation and the inhibition of colony‐stimulating factor‐1‐induced macrophage proliferation by tumor necrosis factor‐α, interferon‐γ, and lipopolysaccharide

Journal of Cellular Physiology

Volumn 151, Issue 3, 1992, Pages 630-641

  Vairo, Gino ^a   Royston, A Keith ^a   Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COLONY STIMULATING FACTOR 1; CYCLIC AMP; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE PHASE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; MACROPHAGE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTON SODIUM EXCHANGE; TUMOR NECROSIS;

ANIMAL; BONE MARROW CELLS; CARRIER PROTEINS; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; DINOPROSTONE; DNA; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED CBA; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; MURINAE;

EID: 0026659563     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041510324     Document Type: Article

References (54)

1. Involvement of common and cell type‐specific pathways by c‐fos gene control: stable induction by cAMP in macrophages
2. The synergistic influence of human interferon‐γ and interferon‐α on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro
3. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon‐γ
4. +
5. Selective inhibition of growth‐related gene expression in murine keratinocytes by transforming growth factor β
6. Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with tumor necrosis factor
7. Inhibitory effects of interferon on the expression of genes regulated by platelet‐derived growth factor
8. Regulation of macrophage growth and antiviral activity by interferon γ
9. Molecular mechanisms of signal transduction in macrophages
10. Activation and proliferation signals in murine macrophages. Synergistic interactions between the hemopoietic growth factors and with phorbol ester for DNA synthesis
11. Activation and proliferation signals in murine macorphages: relationships among c‐fos and c‐myc expression, phos‐phoinositide hydrolysis, superoxide formation, and DNA synthesis
12. Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase‐type plasminogen activator activity by colony stimulating factors and other agents
13. IFN‐γ inhibits C‐myc gene expression by impairing the splicing process in a colony‐stimulating factor dependent murine myeloid cell line
14. Synergistic activation of human monocytes by granulocyte‐macrophage colony stimulating factor and interferon γ. Increased tumor necrosis factor but not IL‐1 activity
15. A c‐myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from GO to G1
16. Interferons in rheumatoid arthritis: alterations in production and response related to disease activity
17. Tumor necrosis factor α stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony‐stimulating factor
18. Recombinant interferon‐γ inhibits the mitogenic effect of platelet‐derived growth factor at a level distal to the growth factor receptor
19. cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S‐phase growth arrest
20. 2 inhibition of growth in a colony‐stimulating factor 1‐dependent macrophage cell line
21. Characterisation of CGS 8515 as a selective 5‐lipoxygenase inhibitor using in vitro and in vivo models
22. Induction of prostaglandin E synthesis in normal and neoplastic macrophages: Role for colony‐stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation
23. Growth inhibition by TGF‐β linked to suppression of retinoblastoma protein phosphorylation
24. 2 and cAMP
25. The antiproliferative effect of type β transforming growth factor occurs at a level distal from receptors for growth activating factors
26. Protein measurement with the Folin phenol reagent
27. Post‐receptor signalling pathways
28. Role of lipopolysaccharide in regulating colony‐stimulating factor‐dependent macrophage proliferation in vitro
29. Expression of cellular oncogenes
30. Induction of c‐fos during myelomonocytic differentiation and macrophage proliferation
31. Cellular processing of murine colony‐stimulating factor (Multi‐CSF, GM‐CSF, G‐CSF) receptors by normal hemopoietic cells and cell lines
32. G1 events and regulation of cell proliferation
33. Phorbol ester‐stimulated superoxide production by murine bone marrow‐derived macrophages requires pre‐exposure to cytokines
34. Transforming growth factor β1 suppression of c‐myc gene transcription: Role in inhibition of keratinocyte proliferation
35. β genes
36. Myc rescue of a mutant CSF‐1 receptor impaired in mitogenic signalling
37. Early signals in the mitogenic response
38. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses
39. Autocrine growth factors and cancer
40. The regulation of macrophage protein turnover by a colony stimulating factor CSF‐1
41. The regulation of mononuclear phagocyte entry into S‐phase by the colony‐stimulating factor CSF‐1
42. + uptake in mouse bone marrow‐derived macrophages
43. +‐ATPase activity by hemopoietic growth factors and other agents
44. Signalling through CSF receptors
45. Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. Lack of effect on early responses to colony stimulating factor‐1
46. 1 of the cell cycle but not for early growth factor responses
47. Inhibition of colony‐stimulating factor‐stimulated macrophage proliferation by tumor necrosis factor α, interferon γ, and lipopolysaccharide is not due to a general loss of responsiveness to growth factor
48. + antiport activation
49. Bone marrow‐derived macrophages: development and regulation of differentiation markers by colony‐stimulating factor and interferons
50. Regulation of MHC class II gene expression in macrophages by colony‐stimulating factors (CSF). Induction by Granulocyte/Macrophage CSF and inhibition by CSF‐1
51. Plasminogen activator‐specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion